Etiometry Recognized as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

News and Press Releases

October 6, 2025- BOSTON — Etiometry is thrilled to announce its selection as a finalist for the prestigious 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH. Etiometry  was chosen as a finalist for the Best In Class  – AI For Patient Care category.

Earlier this year, Etiometry was named one of 16 quarterfinalists, and now the company has advanced to the final four, selected from thousands of submissions worldwide.

This recognition highlights the company’s dedication to empower clinicians with actionable insights that improve patient outcomes, optimize care delivery, and advance the standard of critical care through AI-driven decision support. The Digital Health Hub Awards celebrate organizations that demonstrate excellence in leveraging digital advancements to enhance healthcare services and patient outcomes. 

The Digital Health Hub Foundation Awards honor organizations making strides in improving healthcare speed, efficiency and equity with their digital innovations. Being named a finalist reflects Etiometry’s  commitment to driving meaningful change in the healthcare landscape.

“Being named a finalist for the Digital Health Hub Awards is an incredible honor for our team,” said Shane Cooke, President & CEO of Etiometry. “Every day, we’re driven by the belief that technology should make a real difference in patient care. This recognition validates our mission to support clinicians with tools that not only improve patient outcomes, but also bring greater confidence and clarity to the critical care decisions they face.”

From a pool of more than 1,800 submissions, only the most promising companies in each track and category have advanced to this stage.

“Congratulations to all of our 2025 finalists! Being recognized from among thousands of submissions is an incredible accomplishment. Your work is setting new standards in healthcare innovation, and we are proud to honor your progress. We look forward to celebrating the finalists and winners at HLTH,” said Mark H. Goldstein, Chairman of the Digital Health Hub Foundation.

The 2025 winners will be presented live across multiple stages on October 20 at HLTH and celebrated before an audience of global healthcare leaders, investors, and innovators.

###


About Digital Health Hub Foundation:

Our mission is to help the world’s next best innovative healthcare companies scale and grow. Founded in 2017, on the campus of UCSF in San Francisco, our now 30,000 member community consists of thousands of early-to late-stage healthcare companies and highly qualified healthcare industry providers, payors, experts, mentors, investors, clinicians and researchers who participate in our annual awards ceremony where we bring together

the industry to honor and validate the best of the best and celebrate the technological advances in healthcare and the impact it has.


About Etiometry

Founded in 2010, Etiometry is a leader in clinical decision-support software designed to help clinicians in intensive care units make data-driven, proactive decisions. By leveraging advanced analytics and AI-powered insights, the company empowers care teams to detect subtle changes in patient conditions, prevent complications, and improve recovery times.

Etiometry has received ten FDA clearances and is trusted by leading healthcare institutions worldwide, including top-ranked academic medical centers and pediatric hospitals. The company is committed to advancing patient safety, improving clinical efficiency, and lowering the cost of care through smarter data utilization.

To learn more, visit www.etiometry.com.

Media Contact

Hyedi Nelson
Bellmont Partners
Hyedi@bellmontpartners.com
651-757-7054


Related

New Study Validates Non-Invasive Prediction of Carbon Dioxide Retention in Neonates Using Etiometry’s Clinical Intelligence Platform

September 9, 2025 – BOSTON – A newly published study in the Journal of Perinatology has validated a breakthrough predictive tool, IVCO2, that accurately estimates the risk of carbon dioxide (CO2) retention in neonates using Etiometry’s Clinical Intelligence Platform. Unlike traditional monitoring methods that rely on skin sensors and can compromise the skin integrity of […]

Why Measuring Key Clinical Markers Matters in Cardiogenic Shock

Cardiogenic shock (CS) remains a critical issue in hospitals nationwide. Despite advances in interventional cardiology, CS is a high-mortality condition, with mortality ranges from 30% to 40%, and 1-year mortality approaches or exceeds 50%. One of the main challenges is the rapid progression of CS severity. Historically, staging using the Society for Cardiovascular Angiography and […]